ObsEva SA (OBSV): Price and Financial Metrics
OBSV Price/Volume Stats
| Current price | $0.10 | 52-week high | $2.14 |
| Prev. close | $0.12 | 52-week low | $0.08 |
| Day low | $0.10 | Volume | 8,230,800 |
| Day high | $0.12 | Avg. volume | 8,942,389 |
| 50-day MA | $0.17 | Dividend yield | N/A |
| 200-day MA | $0.46 | Market Cap | 7.94M |
OBSV Stock Price Chart Interactive Chart >
ObsEva SA (OBSV) Company Bio
ObsEva SA, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women between the ages of 15 and 49 suffering from reproductive health and pregnancy. The company intends to develop treatments for treating endometriosis, uterine fibroids, and preterm labor. The company was founded in 2012 and is based in Switzerland.
Latest OBSV News From Around the Web
Below are the latest news stories about OBSEVA SA that investors may wish to consider to help them evaluate OBSV as an investment opportunity.
ObsEva Announces Progress Towards its Plans to Consolidate Operations in Switzerland: Delisting of OBSV from The Nasdaq Stock Market effective March 23, 2023Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 15, 2023 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that it received a notification letter from The Nasdaq Stock Market LLC (“Nasdaq”) on March 14, 2023, advising the Company that its securities are scheduled for delisting from The Nasdaq Capital Market and will be suspended at the opening of U. |
ObsEva Announces Update Towards its Strategic Reorganization to Consolidate Operations in SwitzerlandAd hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – March 13, 2023 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced that Ernest Loumaye, MD, PhD, co-founder and member of the Board of Directors has been appointed as Interim Chairman following the resignation of Annette Clancy. It is expected that Dr. Loumaye will serve in this position until the 2023 Annual |
10 Penny Stocks with Insider BuyingIn this piece, we will take a look at ten penny stocks with insider buying. For more penny stocks, head on over to 5 Penny Stocks with Insider Buying. With the first quarter of 2023 coming to an end, the stock market continues to be in a topsy-turvy environment. 2023 was off to a strong […] |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayWe're getting into the biggest pre-market stock movers traders will want to keep an eye on Wednesday with the latest news! |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on FridayWe're starting off Friday morning with a breakdown of the biggest pre-market stock movers traders need to keep an eye on! |
OBSV Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -96.68% |
| 5-year | -99.28% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -92.71% |
| 2021 | -4.33% |
| 2020 | -45.55% |
| 2019 | -69.83% |
Loading social stream, please wait...